Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct
properties by changing the precursors and the flow rates, significantly decreasing the time …

In the formulation of nanoparticles, poly (lactic-co-glycolic acid)(PLGA) is commonly
employed due to its Food and Drug Administration and European Medicines Agency …

Poly (lactic-co-glycolic acid)(PLGA) is a biocompatible and biodegradable polymer that
recently attracted attention for use as part of drug delivery systems (DDS). In this context …

Polymeric particles made up of biodegradable and biocompatible polymers such as poly
(lactic-co-glycolic acid)(PLGA) are promising tools for several biomedical applications …

Particle size is a key feature in determining performance of nanoparticles as drug carriers
because it influences circulating half-life, cellular uptake and biodistribution. Because the …

In recent years, there have been a plethora of nanoengineering approaches for the
development of poly (lactide‐co‐glycolide)(PLGA) nanoparticulate carrier systems …

Nanomedicines based on poly (lactic-co-glycolic acid)(PLGA) carriers offer tremendous
opportunities for biomedical research. Although several PLGA-based systems have already …

The efficient and reproducible production of nanoparticles using bulk nanoprecipitation
methods is still challenging because of low batch to batch reproducibility. Here, we optimize …

Microfluidics is a promising system for efficiently optimizing the experimental conditions for
preparing nanomedicines, such as self-assembled nanoparticles. Poly (lactic-co-glycolic …

Nanocarriers formulated with the US Food and Drug Administration-approved biocompatible
and biodegradable polymer poly (lactic-co-glycolic acid)(PLGA) are being widely explored …